Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of DMF in SPMS
NCT02683863Phase 4Completed
- Start
- Aug 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dimethyl fumarate in secondary-progressive multiple sclerosis (SPMS) (4 arms). Primary endpoints: Pharmacokinetics of DMF in CSF at Week 6, Pharmacokinetics of DMF in Plasma at Week 6 and 6 more. Started Aug 2015; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT02683863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683863.